you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Apr 19, 13:35
576.90 5.00 (0.87%)
Volume
AVERAGE VOLUME
5-Day
436,384
10-Day
314,425
30-Day
167,309
559,995
  • Prev. Close

    571.90

  • Open Price

    572.00

  • Bid Price (Qty.)

    576.50 (25)

  • Offer Price (Qty.)

    576.90 (54)

NSE Live

Apr 19, 13:35
576.60 4.70 (0.82%)
Volume
AVERAGE VOLUME
5-Day
8,098,368
10-Day
5,350,010
30-Day
2,767,030
10,714,072
  • Prev. Close

    571.90

  • Open Price

    570.00

  • Bid Price (Qty.)

    576.60 (230)

  • Offer Price (Qty.)

    576.70 (3)

Financials

2020 2019 2018 2017 2016
Yearly Results of Glenmark Pharma (in Rs. Cr.) Mar '20 Mar '19 Mar '18 Mar '17 Mar '16  
Net Sales/Income from operations 6,491.20 6,131.14 6,096.05 7,694.83 5,906.97  
Other Operating Income 221.43 173.73 335.83 400.67 296.11  
Total Income From Operations 6,712.63 6,304.87 6,431.88 8,095.50 6,203.08  
EXPENDITURE  
Consumption of Raw Materials 2,251.98 1,585.85 2,038.57 2,242.01 1,792.24  
Purchase of Traded Goods 365.24 301.30 288.18 267.00 219.98  
Increase/Decrease in Stocks 48.77 471.81 51.85 -83.52 -73.55  
Power & Fuel -- -- -- -- --  
Employees Cost 1,072.33 969.98 1,021.92 914.47 766.25  
Depreciation 138.54 106.28 118.20 104.93 99.81  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,670.08 1,648.45 1,683.87 1,856.90 1,732.98  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,165.69 1,221.20 1,229.30 2,793.71 1,665.37  
Other Income 606.79 475.61 180.42 148.24 117.38  
P/L Before Int., Excpt. Items & Tax 1,772.48 1,696.81 1,409.72 2,941.95 1,782.75  
Interest 256.39 223.81 190.90 152.60 36.22  
P/L Before Exceptional Items & Tax 1,516.09 1,473.00 1,218.83 2,789.35 1,746.53  
Exceptional Items 18.55 345.19 -- -236.45 --  
P/L Before Tax 1,534.64 1,818.18 1,218.83 2,552.90 1,746.53  
Tax 180.10 329.88 204.48 412.29 262.26  
P/L After Tax from Ordinary Activities 1,354.55 1,488.30 1,014.35 2,140.61 1,484.27  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- 133.81 -- -- --  
Net Profit/(Loss) For the Period 1,354.55 1,622.11 1,014.35 2,140.61 1,484.27  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves 13,198.05 11,913.87 10,363.22 9,408.40 7,337.75  
Equity Dividend Rate (%) 250.00 200.00 200.00 200.00 200.00  
EPS Before Extra Ordinary  
Basic EPS 48.00 52.75 35.95 75.86 52.94  
Diluted EPS 48.00 52.74 35.94 75.84 52.93  
EPS After Extra Ordinary  
Basic EPS. 48.00 52.75 35.95 75.86 52.94  
Diluted EPS. 48.00 52.74 35.94 75.84 52.93  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited